INTRICON CORP (IIN)
US46121H1095 - Common Stock
Overall IIN gets a fundamental rating of 4 out of 10. We evaluated IIN against 192 industry peers in the Health Care Equipment & Supplies industry. The financial health of IIN is average, but there are quite some concerns on its profitability. IIN is valued quite expensive, but it does show an excellent growth.
1. Profitability
1.1 Basic Checks
IIN had positive earnings in the past year.
In multiple years IIN reported negative net income over the last 5 years.
IIN had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.17% | ||
| ROE | 1.03% | ||
| ROIC | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.27% | ||
| PM (TTM) | -1.17% | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
The number of shares outstanding for IIN has been increased compared to 1 year ago.
Compared to 1 year ago, IIN has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 5.50 indicates that IIN is not in any danger for bankruptcy at the moment.
IIN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 5.5 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
A Current Ratio of 3.20 indicates that IIN has no problem at all paying its short term obligations.
IIN has a Quick Ratio of 2.01. This indicates that IIN is financially healthy and has no problem in meeting its short term obligations.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.2 | ||
| Quick Ratio | 2.01 |
3. Growth
3.1 Past
IIN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1200.00%, which is quite impressive.
Measured over the past years, IIN shows a quite strong growth in Earnings Per Share. The EPS has been growing by 14.50% on average per year.
The Revenue has grown by 11.90% in the past year. This is quite good.
IIN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.66% yearly.
EPS 1Y (TTM)1200%
EPS 3Y-5.9%
EPS 5Y14.5%
EPS growth Q2Q-196.47%
Revenue 1Y (TTM)11.9%
Revenue growth 3Y3.21%
Revenue growth 5Y12.66%
Revenue growth Q2Q4.06%
3.2 Future
Based on estimates for the next years, IIN will show a very strong growth in Earnings Per Share. The EPS will grow by 85.86% on average per year.
The Revenue is expected to grow by 13.78% on average over the next years. This is quite good.
EPS Next Y-13.69%
EPS Next 2Y38.86%
EPS Next 3Y68.37%
EPS Next 5Y85.86%
Revenue Next Year10.43%
Revenue Next 2Y14.04%
Revenue Next 3Y13.68%
Revenue Next 5Y13.78%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 44.07, which means the current valuation is very expensive for IIN.
When comparing the Price/Earnings ratio of IIN to the average of the S&P500 Index (24.55), we can say IIN is valued expensively.
With a Price/Forward Earnings ratio of 22.86, IIN is valued on the expensive side.
IIN is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 20.92, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 44.07 | ||
| Fwd PE | 22.86 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 28.47 |
4.3 Compensation for Growth
A more expensive valuation may be justified as IIN's earnings are expected to grow with 68.37% in the coming years.
PEG (NY)N/A
PEG (5Y)3.04
EPS Next 2Y38.86%
EPS Next 3Y68.37%
5. Dividend
5.1 Amount
IIN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
INTRICON CORP
NASDAQ:IIN (5/24/2022, 7:00:02 PM)
After market: 24.25 +0.01 (+0.04%)24.24
+0.01 (+0.04%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap225.49M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 44.07 | ||
| Fwd PE | 22.86 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)3.04
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.17% | ||
| ROE | 1.03% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 1.27% | ||
| PM (TTM) | -1.17% | ||
| GM | N/A | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 3.2 | ||
| Quick Ratio | 2.01 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)1200%
EPS 3Y-5.9%
EPS 5Y
EPS growth Q2Q
EPS Next Y-13.69%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)11.9%
Revenue growth 3Y3.21%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y